Hearing Loss News and Research

Latest Hearing Loss News and Research

New analysis reveals high rates of CNS disorders in autistic children

Nearly two-thirds of the children with Autistic Spectrum Disorders recorded in the National Birth Defect Registry (NBDR) also suffer from structural birth defects, according the national nonprofit, Birth Defect Research for Children (BDRC).

20 Jan 2010

GenVec and Novartis collaborate to develop novel treatments for hearing loss and balance disorders

GenVec and Novartis will collaborate to discover and develop novel treatments for hearing loss and balance disorders. Preclinical results suggest that delivery of the atonal gene using GenVec's innovative adenovector technology may have the potential to restore hearing and balance function.

19 Jan 2010

Fertility drugs cause a high percentage of multiple births; contribute to growing crisis of prematurity

The widespread use of so-called fertility drugs, not just high-tech laboratory procedures, likely plays a larger role than previously realized in the growing problem of premature births in the United States, because these drugs cause a high percentage of multiple births, the March of Dimes said today.

18 Jan 2010

GeckoSystems continue to better understand the benefit of personal care robots

GeckoSystems Intl. Corp. (http://www.geckosystems.com/) announced today that they continue to better understand the benefit of personal care robots, such as their CareBot™, to the family as their in home evaluation trials continue.

13 Jan 2010

Findings may pave way for significant advancements in cochlear implant technology for hearing loss

Loss of spiral ganglion neurons or hair cells in the inner ear is the leading cause of congenital and acquired hearing impairment. Researchers at the University of California, San Diego, School of Medicine and the National Institutes of Health found that Sox2, a protein that regulates stem cell formation, is involved in spiral ganglion neuron development. The study was published in the January 13 issue of the Journal of Neuroscience.

13 Jan 2010

Caffeine abstinence: An ineffective and potentially distressing tinnitus therapy

New research has found giving up caffeine does not relieve tinnitus and acute caffeine withdrawal might add to the problem. This is the first study of its kind to look at the effect of caffeine consumption on tinnitus.

13 Jan 2010

Phonak's "Hear the World Tour" exhibit to raise hearing loss awareness at Miami

The Hear the World initiative by Phonak will bring the Hear the World Tour - a traveling photography exhibit - to Macy's at Dadeland Mall (Miami, FL) to raise awareness about hearing loss, a growing issue that affects 31 million Americans. After officially joining forces in October 2009, Phonak and Macy's kicked-off a cross-country hearing awareness tour that debuted in Dallas and San Francisco in the fall.

9 Jan 2010

Gene therapy may help correct molecular flaws that cause brain disease

Neuroscientists have forged an unlikely molecular union as part of their fight against diseases of the brain and nervous system.

9 Jan 2010

Untreated hearing loss can put personal safety and overall health at risk

With hearing loss in America approaching what medical researchers say may be epidemic proportions, a top hearing care executive is calling for this to be the year that hearing care is recognized as a medical necessity.

6 Jan 2010

Sonova completes acquisition of Insound Medical, sees growth potential in Lyric brand of hearing systems

Sonova Holding AG, the world’s leading provider of hearing systems, announced today that it has successfully completed its acquisition of InSound Medical Inc., Newark, USA. InSound Medical developed the first extended wear hearing system which is placed deep in the ear canal and totally invisible from the outside, and markets it under the Lyric® brand.

6 Jan 2010

UC researchers receive $2.5 million grant to study treatment for voice disorders

For patients with severe voice disorders, the loss of their voice often means losing their social life, self esteem or livelihood. While existing therapies can treat mild to moderate voice disorders, physicians have a harder time determining effective treatments for those with severe cases.

30 Dec 2009

Tel Aviv University's new Genome Analyzer fuels research dreams and tomorrow's cures

To identify the hemophilia mutation that affected Queen Victoria and her European relatives, scientific detectives used a cutting-edge "deep sequencing tool." Able to trace rare genetic disease mutations, the tool can turn a single laboratory into a fertile genetic research center.

22 Dec 2009

Shire submits REPLAGAL BLA with the FDA

Shire plc , the global specialty biopharmaceutical company, today announced that it has submitted a BLA with the FDA for REPLAGAL(R) (agalsidase alfa), its enzyme replacement therapy for Fabry disease. REPLAGAL first received marketing authorization in the European Union in 2001, and is approved for the treatment of Fabry disease in 45 countries.

22 Dec 2009

NMA urges parents to protect their children from meningococcal disease

This winter, while many parents are focused on influenza prevention, the National Meningitis Association (NMA) is urging parents to also protect their families from meningococcal disease, a deadly but potentially vaccine preventable bacterial infection.

22 Dec 2009

Advisory Panel of independent ENT experts recommends FDA to approve Envoy Medical's Esteem

Envoy Medical, a Minnesota corporation, has developed the first Fully Implantable Hearing Restoration System known as the Esteem®. On December 18th, an Advisory Panel of independent ENT experts unanimously recommended that the FDA approve the Esteem®.

22 Dec 2009

HearAtLast Holdings to continue its expansion throughout 2010 and 2011 in North America

HearAtLast Holdings, Inc., a leading provider of suitable affordable solutions to clients with hearing needs in the billion dollar hearing loss market, today announced that it will continue its expansion throughout 2010 and 2011 in North America.

19 Dec 2009

PRPS1 gene associated with DFN2 identified by researchers

A gene associated with a rare form of progressive deafness in males has been identified by an international team of researchers funded by the National Institute on Deafness and Other Communication Disorders.

17 Dec 2009

Sonomax Hearing Healthcare attains Phase IV milestone in its off-the-shelf, custom earpieces development

Sonomax Hearing Healthcare Inc. attains the Phase IV milestone and is only one milestone away from successfully completing the development of its off-the-shelf, self-fitting custom earpieces.

17 Dec 2009

Investigational study of TRT to alleviate debilitating effects of tinnitus commenced

A University of Alabama researcher is embarking on a $5.6 million phase-three, randomized, controlled clinical trial to evaluate the effectiveness of an innovative treatment that uses a noise-generating device, along with counseling, to alleviate the debilitating effects of tinnitus - that ringing in the ears that drives some people to distraction.

17 Dec 2009

GeckoSystems Intl. upgrades CareBot's voice synthesis capability

GeckoSystems Intl. Corp. announced today that they have recently improved their voice synthesis capability due to insights from their in home personal companion eldercare robot evaluation trials. GeckoSystems is a dynamic leader in the emerging Mobile Service Robot industry revolutionizing their development and usage with "Mobile Robot Solutions for Safety, Security and Service™."

16 Dec 2009

Hearing Loss News and Research

Latest Hearing Loss News and Research

New analysis reveals high rates of CNS disorders in autistic children

GenVec and Novartis collaborate to develop novel treatments for hearing loss and balance disorders

Fertility drugs cause a high percentage of multiple births; contribute to growing crisis of prematurity

GeckoSystems continue to better understand the benefit of personal care robots

Findings may pave way for significant advancements in cochlear implant technology for hearing loss

Caffeine abstinence: An ineffective and potentially distressing tinnitus therapy

Phonak's "Hear the World Tour" exhibit to raise hearing loss awareness at Miami

Gene therapy may help correct molecular flaws that cause brain disease

Untreated hearing loss can put personal safety and overall health at risk

Sonova completes acquisition of Insound Medical, sees growth potential in Lyric brand of hearing systems

UC researchers receive $2.5 million grant to study treatment for voice disorders

Tel Aviv University's new Genome Analyzer fuels research dreams and tomorrow's cures

Shire submits REPLAGAL BLA with the FDA

NMA urges parents to protect their children from meningococcal disease

Advisory Panel of independent ENT experts recommends FDA to approve Envoy Medical's Esteem

HearAtLast Holdings to continue its expansion throughout 2010 and 2011 in North America

PRPS1 gene associated with DFN2 identified by researchers

Sonomax Hearing Healthcare attains Phase IV milestone in its off-the-shelf, custom earpieces development

Investigational study of TRT to alleviate debilitating effects of tinnitus commenced

GeckoSystems Intl. upgrades CareBot's voice synthesis capability

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Hearing Loss News and Research

Latest Hearing Loss News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in